PE20080887A1 - Composiciones de carbamatos de fenilalquilo - Google Patents

Composiciones de carbamatos de fenilalquilo

Info

Publication number
PE20080887A1
PE20080887A1 PE2007001383A PE2007001383A PE20080887A1 PE 20080887 A1 PE20080887 A1 PE 20080887A1 PE 2007001383 A PE2007001383 A PE 2007001383A PE 2007001383 A PE2007001383 A PE 2007001383A PE 20080887 A1 PE20080887 A1 PE 20080887A1
Authority
PE
Peru
Prior art keywords
composition
phenylalkyl carbamate
refers
found
phenyl
Prior art date
Application number
PE2007001383A
Other languages
English (en)
Inventor
Ramendra N Pandey
Tracey Mascaro
Ronnie Mcdowell
John Troisi
James Mccool
Stanley Altan
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39111848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080887(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PE20080887A1 publication Critical patent/PE20080887A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UN COMPUESTO CARBAMATO DE FENILALQUILO DE FORMULA (I) DONDE X ES HALOGENO, R1 Y R2 SON CADA UNO H O ALQUILO(C1-C4) OPCIONALMENTE SUSTITUIDO CON FENILO, SIENDO UN COMPUESTO PREFERIDO 2-(2-CLORO-FENIL)-2-HIDROXI-ETIL ESTER DEL ACIDO CARBAMICO Y SE ENCUENTRA EN UNA CANTIDAD DE 75% A 99% DE LA COMPOSICION; B) FOSFATO DE CALCIO DIBASICO DIHIDRATADO QUE REDUCE LA DEGRADACION DEL COMPUESTO CARBAMATO DE FENILALQUILO, PRESENTA UN pH DE 5,0 A 5,8 Y SE ENCUENTRA EN UNA CANTIDAD DE 4% A 40% DE LA COMPOSICION; C) OTROS EXCIPIENTES TALES COMO CELULOSA MICROCRISTALINA, LACTOSA, MANITOL, POLIETILENGLICOL, ESTEARATO DE MAGNESIO, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE LA COMPOSICION. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE EPILEPSIA, ESPASMO MUSCULAR, ACCIDENTE CEREBROVASCULAR
PE2007001383A 2006-10-13 2007-10-12 Composiciones de carbamatos de fenilalquilo PE20080887A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82935506P 2006-10-13 2006-10-13

Publications (1)

Publication Number Publication Date
PE20080887A1 true PE20080887A1 (es) 2008-06-28

Family

ID=39111848

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001383A PE20080887A1 (es) 2006-10-13 2007-10-12 Composiciones de carbamatos de fenilalquilo

Country Status (23)

Country Link
US (1) US20080090903A1 (es)
EP (1) EP2089002A1 (es)
JP (1) JP2010506846A (es)
KR (1) KR20090067210A (es)
CN (1) CN101663026A (es)
AR (1) AR063294A1 (es)
AU (1) AU2007313018A1 (es)
BR (1) BRPI0719236A2 (es)
CA (1) CA2673526A1 (es)
CL (1) CL2007002943A1 (es)
CO (1) CO6190539A2 (es)
CR (1) CR10793A (es)
EA (1) EA200970378A1 (es)
IL (1) IL198144A0 (es)
MX (1) MX2009003929A (es)
NI (1) NI200900055A (es)
NO (1) NO20091492L (es)
PE (1) PE20080887A1 (es)
SV (1) SV2009003222A (es)
TW (1) TW200831134A (es)
UY (1) UY30643A1 (es)
WO (1) WO2008048802A1 (es)
ZA (1) ZA200903284B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263652B2 (en) * 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
BR112013000050B1 (pt) * 2010-07-02 2021-10-19 Bio-Pharm Solutions Co., Ltd Compostos de carbamato de fenila e composição farmacêutica
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN104870421A (zh) 2011-12-27 2015-08-26 比皮艾思药物研发有限公司 用于预防或治疗als的苯基氨基甲酸酯化合物
WO2014097137A2 (en) * 2012-12-18 2014-06-26 Mahesh Kandula Compositions and methods for the treatment of seizures and neurologic diseases
KR101717872B1 (ko) * 2013-03-12 2017-03-17 (주)바이오팜솔루션즈 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물
CN105209430B (zh) * 2013-03-12 2019-09-13 比皮艾思药物研发有限公司 苯基氨基甲酸酯化合物及包含其的神经保护组合物
KR102213484B1 (ko) * 2016-02-29 2021-02-08 (주)바이오팜솔루션즈 카바메이트 유도체 화합물, 이의 제조 방법 및 용도
KR102121680B1 (ko) * 2016-02-29 2020-06-10 (주)바이오팜솔루션즈 설파메이트 유도체 화합물, 이의 제조 방법 및 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US20020147229A1 (en) * 2000-08-17 2002-10-10 Allerton Charlotte Moira Norfor Pharmaceuticals
BR0213634A (pt) * 2001-10-08 2004-11-30 Sun Pharmaceutical Ind Ltd Sistema de liberação de droga com ação retardada para um agente antiespasmódico

Also Published As

Publication number Publication date
CA2673526A1 (en) 2008-04-24
UY30643A1 (es) 2008-05-02
CN101663026A (zh) 2010-03-03
NI200900055A (es) 2010-02-01
BRPI0719236A2 (pt) 2014-07-08
CO6190539A2 (es) 2010-08-19
AU2007313018A1 (en) 2008-04-24
TW200831134A (en) 2008-08-01
IL198144A0 (en) 2009-12-24
JP2010506846A (ja) 2010-03-04
AR063294A1 (es) 2009-01-21
EA200970378A1 (ru) 2009-10-30
KR20090067210A (ko) 2009-06-24
EP2089002A1 (en) 2009-08-19
US20080090903A1 (en) 2008-04-17
MX2009003929A (es) 2009-06-26
NO20091492L (no) 2009-07-09
WO2008048802A1 (en) 2008-04-24
CR10793A (es) 2009-09-29
CL2007002943A1 (es) 2008-04-18
SV2009003222A (es) 2009-10-15
ZA200903284B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
PE20080887A1 (es) Composiciones de carbamatos de fenilalquilo
AR047993A1 (es) Composicion farmaceutica que comprende pimobendano
ATE499940T1 (de) Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
PE20090649A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
EA201070597A1 (ru) Антибактериальные аналоги аминогликозида
PE20201500A1 (es) Inhibidores de glicolato oxidasa para el tratamiento de enfermedades
PE20060176A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparacion, y su empleo como medicamentos
AR077252A1 (es) Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
PE20120028A1 (es) Nueva composicion a base de acido gamma-hidroxibutirico
ECSP088765A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
PE20080832A1 (es) Compuestos de n-metilaminometil isoindol y composiciones que los comprenden
EA201171109A1 (ru) Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия
UA86614C2 (ru) Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
NZ591810A (en) Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
BRPI0608097A2 (pt) composto ou enanciÈmeros, diastereÈmeros, sais, solvatos e n-óxidos do mesmo, composição farmacêutica, e,uso de uma quantidade eficaz de um composto
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
MX2011013201A (es) Composiciones para tratar adiccion a drogas y para mejorar comportamiento relacionado a la adiccion.
NZ619076A (en) Isoxazolines as inhibitors of fatty acid amide hydrolase
BR112014015568A8 (pt) compostos carbamato de fenila para uso em prevenção ou tratamento de epilepsia
AR083879A1 (es) Analogos de aminoglicosidos antibacterianos, metodos de preparacion y uso como agentes terapeuticos
NO20051896L (no) Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav
ITBO20110012A1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BRPI0506493A (pt) combinações terapêuticas
MX2009003926A (es) Composiciones de fenilalquilamino-carbamato.
BR112012025590A2 (pt) análogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119

Legal Events

Date Code Title Description
FC Refusal